florfenicol
Commercial- Indications
- Animal bacterial infections
Company intelligence / Profile preview
Hubei Longxiang Pharmaceutical is a leading Chinese manufacturer of veterinary active pharmaceutical ingredients (APIs) and finished preparations. The company holds GMP certification from the China Ministry of Agriculture and produces both raw materials and formulated products for animal health applications. Its portfolio includes widely used antibiotics and antiparasitics such as florfenicol, tilmicosin, toltrazuril, oxolinic acid, valnemulin hydrochloride, ponazuril among others. The company is recognized as a high-tech enterprise in Hubei province with significant production capacity.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Longxiang Pharmaceutical.